🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this study is to evaluate whether prophylactic endoscopic varic...
Status
Recruiting
Location
Liver cancer center, Asan Medical Center
Start Date
2025-05-28
Trial ID
NCT06819566
Treatments Being Tested
This is an open labeled, non-randomized adaptive pilot study. The study int...
Status
Terminated
Location
Chevy Chase RCCA
Start Date
2018-09-25
Trial ID
NCT03721679
International, randomised, open label, neo-adjuvant phase II trial in women...
Status
Active Not Recruiting
Location
Barts Health NHS Trust
Start Date
2018-12-19
Trial ID
NCT05498896
Treatments Being Tested
This is a Phase Ib/II, open-label, multicenter, randomized platform study t...
Status
Completed
Location
University of Southern California (USC)
Start Date
2023-12-05
Trial ID
NCT05908786
Treatments Being Tested
This phase Ib trial tests the safety, side effects, and best dose of tumor ...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2022-04-29
Trial ID
NCT05092373
Treatments Being Tested
This is to study if neoadjuvant atezolizumab therapy is beneficial for pati...
Status
Recruiting
Location
University of California, San Francisco
Start Date
2024-03-21
Trial ID
NCT06069726
Treatments Being Tested
This is an open-label, multicenter, single-arm, expanded access program (EA...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
2015-11
Trial ID
NCT02589717
Treatments Being Tested
This trial will treat patients with platinum resistant ovarian, fallopian t...
Status
Recruiting
Location
UPMC Hillman Cancer Center
Start Date
2023-05-15
Trial ID
NCT05538091
Treatments Being Tested
This phase II trial studies how well atezolizumab and bevacizumab work in t...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2017-03-03
Trial ID
NCT03074513
Treatments Being Tested
This is a phase II study, preceded by a safety run-in, with two independent...
Status
Active Not Recruiting
Location
Institut Curie
Start Date
2024-03-27
Trial ID
NCT06175390
Treatments Being Tested